» Articles » PMID: 16877731

Health Status Measurements at Diagnosis As Predictors of Survival Among Adults with Brain Tumors

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2006 Aug 1
PMID 16877731
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The intent of this study was to determine whether baseline measures of functional capacity and performance could be used to predict survival in adults following the diagnosis of brain tumors.

Patients And Methods: Comprehensive health status and health-related quality of life (HRQL) were measured using the Health Utilities Index (HUI; McMaster University, Hamilton, Canada) system by a self-assessment questionnaire in a survey of 100 consecutive patients. The Karnofsky Performance Score (KPS) and Folstein's Mini-Mental State Examination (MMSE) scores were measured by a physician blinded to the HUI results. The patients were observed for up to 5 years to recorded dates of death.

Results: An HUI questionnaire was completed for 93% of the patients and 69% died within 5 years of assessment. The HUI revealed a burden of morbidity and complexity of disability that far exceeded that reported for the general population. KPS and MMSE correlated strongly with each other (r = 0.52; P < .001). A decrease of 0.1 units in HUI Mark 2 (HUI2) self-care single-attribute utility score was associated with an increased hazard of death of 30% (P = .023) for patients with low-grade tumors (n=25). For patients with high-grade tumors (n=56), a 10 unit decrease in the KPS, a 5 unit decrease in MMSE, and a 0.1 decrease in HUI Mark 3 (HUI3) speech and dexterity single-attribute scores were associated with an increased hazard of death of 20% (P = .022), 26% (P = .015), 36% (P = .021), and 18% (P = .035), respectively.

Conclusion: Scores derived from the measurement of HRQL following diagnosis can predict survival in adults with brain tumors.

Citing Articles

Impact of COVID-19 Epidemic on Psycho-Oncological Distress in Neuro-Oncological Patients.

Staub-Bartelt F, Steinmann J, Radtke O, Hanggi D, Sabel M, Rapp M Curr Oncol. 2023; 30(1):358-369.

PMID: 36661678 PMC: 9857307. DOI: 10.3390/curroncol30010029.


Impact of Anticipated Awake Surgery on Psychooncological Distress in Brain Tumor Patients.

Staub-Bartelt F, Radtke O, Hanggi D, Sabel M, Rapp M Front Oncol. 2022; 11:795247.

PMID: 35111678 PMC: 8801942. DOI: 10.3389/fonc.2021.795247.


Cost-utility analysis of apixaban compared with usual care for primary thromboprophylaxis in ambulatory patients with cancer.

Kimpton M, Kumar S, Wells P, Coyle D, Carrier M, Thavorn K CMAJ. 2022; 193(40):E1551-E1560.

PMID: 35040802 PMC: 8568073. DOI: 10.1503/cmaj.210523.


Cost-effectiveness of radiation and chemotherapy for high-risk low-grade glioma.

Qian Y, Maruyama S, Kim H, Pollom E, Kumar K, Chin A Neuro Oncol. 2017; 19(12):1651-1660.

PMID: 28666368 PMC: 5716167. DOI: 10.1093/neuonc/nox121.


Effects of Radiation Exposure on the Cost-Effectiveness of CT Angiography and Perfusion Imaging in Aneurysmal Subarachnoid Hemorrhage.

Ivanidze J, Charalel R, Shuryak I, Brenner D, Pandya A, Kallas O AJNR Am J Neuroradiol. 2017; 38(3):462-468.

PMID: 28082263 PMC: 7960010. DOI: 10.3174/ajnr.A5034.